PBI Stock Analysis: Pitney Bowes | NYSE
Integrated Freight & Logistics | NYSE, USA | Market Cap: 2.259m USD | 12M Return: 43.2% | US7244791007 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 28.4M
Qual. Beats: 1
Rev. Trend: -85.5%
Qual. Beats: 0
Warnings
Tailwinds
Seasonality 11.6 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Pitney Bowes Inc. (PBI) is a U.S.-based provider of digital shipping solutions, mailing technology, and related financial services, operating globally through two reportable segments: SendTech Solutions and Presort Services. The SendTech Solutions segment supplies physical and digital shipping and mailing hardware, software, supplies, and maintenance, and also offers financing alternatives for third-party equipment purchases - a model that extends the companys revenue stream beyond its own product lines. The Presort Services segment operates as a workshare partner of the United States Postal Service, providing presorted mail processing for commercial mailers in exchange for postal discounts, which is a regulated arrangement tied to USPS workshare programs.
The company distributes through direct and inside sales forces, partner channels, direct mail, and digital channels. Pitney Bowes is classified in the Industrials sector under the Office Services & Supplies sub-industry, a group that has faced secular pressure from the ongoing decline in physical mail volumes as communication and commerce shift digital. Headquartered in Shelton, Connecticut, the company was incorporated in 1920 and trades on the NYSE as a mid-cap stock.
- SendTech shipping solutions revenue pressured by e-commerce competition
- Presort Services revenue declines as USPS mail volume contracts
- Equipment financing portfolio drives SendTech segment margins
| Net Income: 187.3m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.14 > 0.02 and ΔFCF/TA 8.64 > 1.0 |
| NWC/Revenue: -20.24% < 20% (prev -18.41%; Δ -1.83% < -1%) |
| CFO/TA 0.16 > 3% & CFO 491.8m > Net Income 187.3m |
| Net Debt (2.00b) to EBITDA (463.1m): 4.32 < 3 |
| Current Ratio: 0.73 > 1.5 & < 3 |
| Outstanding Shares: last quarter (139.0m) vs 12m ago -23.18% < -2% |
| Gross Margin: 54.08% > 18% (prev 53.57%; Δ 0.52% > 0.5%) |
| Asset Turnover: 59.64% > 50% (prev 60.85%; Δ -1.21% > 0%) |
| Interest Coverage Ratio: 3.36 > 6 (EBIT TTM 359.3m / Interest Expense TTM 106.8m) |
| A: -0.13 (Total Current Assets 1.04b - Total Current Liabilities 1.42b) / Total Assets 3.02b |
| B: 0.89 (Retained Earnings 2.70b / Total Assets 3.02b) |
| C: 0.11 (EBIT TTM 359.3m / Avg Total Assets 3.13b) |
| D: -0.22 (Book Value of Equity -863.3m / Total Liabilities 3.88b) |
| Altman-Z'' = 2.63 = A |
| DSRI: 0.99 (Receivables 619.0m/663.6m, Revenue 1.87b/1.97b) |
| GMI: 0.99 (GM 53.57% / 54.08%) |
| AQI: 1.02 (AQ_t 0.56 / AQ_t-1 0.55) |
| SGI: 0.95 (Revenue 1.87b / 1.97b) |
| TATA: -0.10 (NI 187.3m - CFO 491.8m) / TA 3.02b) |
| Beneish M = -3.08 (Cap -4..+1) = AA |
As of August 27, 2026, the stock is trading at USD 17.01 with a total of 1,145,779 shares traded. Over the past week, the price has changed by +5.72%, over one month by -5.74%, over three months by +10.30% and over the past year by +43.21%.
Current recommended Stop Loss: 16.30 (which is 4.2% or 1.3 ATR below the current price).
Pitney Bowes has received a consensus analysts rating of 3.20. Therefore, it is recommended to hold PBI.
- StrongBuy: 0
- Buy: 1
- Hold: 4
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 19.6 | 15% |
P/E Trailing = 13.3984
P/E Forward = 10.3627
P/S = 1.2106
P/B = 9.5693
P/EG = 0.691
Revenue TTM = 1.87b USD
EBIT TTM = 359.3m USD
EBITDA TTM = 463.1m USD
Long Term Debt = 2.01b USD (from longTermDebt, last quarter)
Short Term Debt = 53.1m USD (from shortTermDebt, last quarter)
Debt = 2.28b USD (from shortLongTermDebtTotal, last quarter) + Leases 123.8m
Net Debt = 2.00b USD (calculated: Debt 2.28b - CCE 278.8m)
Enterprise Value = 4.26b USD (2.26b + Debt 2.28b - CCE 278.8m)
Interest Coverage Ratio = 3.36 (Ebit TTM 359.3m / Interest Expense TTM 106.8m)
EV/FCF = 10.11x (Enterprise Value 4.26b / FCF TTM 421.4m)
FCF Yield = 9.89% (FCF TTM 421.4m / Enterprise Value 4.26b)
FCF Margin = 22.58% (FCF TTM 421.4m / Revenue TTM 1.87b)
Net Margin = 10.04% (Net Income TTM 187.3m / Revenue TTM 1.87b)
Gross Margin = 54.08% ((Revenue TTM 1.87b - Cost of Revenue TTM 856.9m) / Revenue TTM)
Gross Margin QoQ = 53.66% (prev 54.41%)
Tobins Q-Ratio = 1.41 (Enterprise Value 4.26b / Total Assets 3.02b)
Interest Expense / Debt = 4.68% (Interest Expense 106.8m / Debt 2.28b)
Taxrate = 25.80% (65.1m / 252.5m)
NOPAT = 266.6m (EBIT 359.3m * (1 - 25.80%))
Current Ratio = 0.73 (Total Current Assets 1.04b / Total Current Liabilities 1.42b)
Debt / Equity = -2.64 (negative equity) (Debt 2.28b / totalStockholderEquity, last quarter -863.3m)
Debt / EBITDA = 4.32 (Net Debt 2.00b / EBITDA 463.1m)
Debt / FCF = 4.75 (Net Debt 2.00b / FCF TTM 421.4m)
Total Stockholder Equity = -805.2m (last 4 quarters mean from totalStockholderEquity)
RoA = 5.99% (Net Income 187.3m / Total Assets 3.02b)
RoE = -23.27% (negative equity) (Net Income TTM 187.3m / Total Stockholder Equity -805.2m)
RoCE = 29.80% (EBIT 359.3m / Capital Employed (Equity -805.2m + L.T.Debt 2.01b))
RoIC = 17.07% (NOPAT 266.6m / Invested Capital 1.56b)
WACC = 6.32% (E(2.26b)/V(4.54b) * Re(9.20%) + D(2.28b)/V(4.54b) * Rd(4.68%) * (1-Tc(0.26)))
Discount Rate = 9.20% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -75.39 | Cagr: -10.17%
[DCF] Terminal Value 77.97% ; FCFF base≈321.7m ; Y1≈368.8m ; Y5≈542.7m
[DCF] Fair Price = 44.97 (EV 8.17b - Net Debt 2.00b = Equity 6.16b / Shares 137.1m; r=8.35% [WACC [floored]]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: N/A | EPS CAGR: N/A | SUE: 1.15 | # QB: 1
Revenue Correlation: -85.55 | Revenue CAGR: -13.31% | SUE: 0.04 | # QB: 0
EPS current Quarter (2026-09-30): EPS=0.35 | Chg30d=-3.19% | Revisions=-40% | Analysts=6
EPS current Year (2026-12-31): EPS=1.68 | Chg30d=+3.50% | Revisions=+57% | GrowthEPS=+24.1% | GrowthRev=-2.4%
EPS next Year (2027-12-31): EPS=1.82 | Chg30d=+4.10% | Revisions=+57% | GrowthEPS=+8.8% | GrowthRev=-0.6%
[Analyst] Revisions Ratio: +46% (up=8, down=2)